* Minerva Surgical Inc UTRS.OQ reported a quarterly
adjusted
loss of 20 cents per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of 21
cents per share.
* Revenue rose 1.2% to $13.80 million from a year ago;
analysts
expected $13.80 million.
* Minerva Surgical Inc's reported EPS for the quarter was a
loss
of 20 cents.
* The mean earnings estimate of analysts had risen by
about 25% in
the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
* Minerva Surgical Inc shares had risen by 5.2% this
quarter.
* The company reported a quarterly loss of $6.25 million.
* Wall Street's median 12-month price target for Minerva
Surgical
Inc is $5.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 22 at 09:36 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.21 -0.20 Beat
Sep. 30 2022 -0.28 -0.40 Missed
Jun. 30 2022 -0.34 -0.20 Beat
Mar. 31 2022 -0.31 -0.38 Missed